Insulet Corp. (PODD)
141.10
+2.33
(+1.68%)
USD |
NASDAQ |
Oct 16, 16:00
141.09
-0.01
(-0.01%)
After-Hours: 20:00
Insulet Cash from Investing (Quarterly) : -37.40M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.40M |
| March 31, 2026 | -27.70M |
| December 31, 2025 | -152.80M |
| September 30, 2025 | -31.00M |
| June 30, 2025 | -23.20M |
| March 31, 2025 | -15.70M |
| December 31, 2024 | -68.00M |
| September 30, 2024 | -29.30M |
| June 30, 2024 | -24.90M |
| March 31, 2024 | -24.00M |
| December 31, 2023 | -31.60M |
| September 30, 2023 | -22.60M |
| June 30, 2023 | -23.10M |
| March 31, 2023 | -42.10M |
| December 31, 2022 | -88.40M |
| September 30, 2022 | -33.90M |
| June 30, 2022 | -21.90M |
| March 31, 2022 | -46.90M |
| December 31, 2021 | -36.40M |
| September 30, 2021 | -12.20M |
| June 30, 2021 | -11.40M |
| March 31, 2021 | -22.70M |
| December 31, 2020 | -51.30M |
| September 30, 2020 | -15.30M |
| June 30, 2020 | 67.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.40M |
| December 31, 2019 | -54.00M |
| September 30, 2019 | 12.19M |
| June 30, 2019 | -39.41M |
| March 31, 2019 | 7.62M |
| December 31, 2018 | -40.78M |
| September 30, 2018 | -26.62M |
| June 30, 2018 | -61.12M |
| March 31, 2018 | -55.99M |
| December 31, 2017 | -149.31M |
| September 30, 2017 | 2.781M |
| June 30, 2017 | -21.98M |
| March 31, 2017 | -42.29M |
| December 31, 2016 | -97.18M |
| September 30, 2016 | -45.04M |
| June 30, 2016 | -37.24M |
| March 31, 2016 | 1.454M |
| December 31, 2015 | -3.482M |
| September 30, 2015 | -7.24M |
| June 30, 2015 | -0.255M |
| March 31, 2015 | -4.346M |
| December 31, 2014 | -2.633M |
| September 30, 2014 | -3.108M |
| June 30, 2014 | -3.588M |
| March 31, 2014 | -2.157M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -2.953M |
| Boston Scientific Corp. | -1.956B |
| Abbott Laboratories | -673.00M |
| DexCom, Inc. | 329.80M |
| The Cooper Cos., Inc. | -69.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 88.50M |
| Cash from Financing (Quarterly) | 4.00M |
| Free Cash Flow | 265.70M |
| Free Cash Flow Per Share (Quarterly) | 0.7377 |
| Free Cash Flow to Equity (Quarterly) | 50.90M |
| Free Cash Flow to Firm (Quarterly) | 62.00M |
| Free Cash Flow Yield | 2.68% |